Literature DB >> 16813753

Should phosphodiesterase 5 selective inhibitors be used for uterine relaxation?

Céline Méhats1, Thomas Schmitz, Michelle Breuiller-Fouché, Marie-Josèphe Leroy, Dominique Cabrol.   

Abstract

Sildenafil citrate is a phosphodiesterase 5-selective inhibitor used successfully in treating erectile dysfunction. High doses of sildenafil can inhibit myometrial contractions. However, no study has demonstrated a role for phosphodiesterase 5 in myometrial contractility. No clinical trial using sildenafil to promote uterine relaxation should be initiated based on the currently available data.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16813753     DOI: 10.1016/j.ajog.2005.12.006

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

Review 1.  A close look at the contraction and relaxation of the myometrium; the role of calcium.

Authors:  Bilge Pehlivanoğlu; Sibel Bayrak; Murat Doğan
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-12-01

Review 2.  Sildenafil during the 2nd and 3rd Trimester of Pregnancy: Trials and Tribulations.

Authors:  Felix Rafael De Bie; David Basurto; Sailesh Kumar; Jan Deprest; Francesca Maria Russo
Journal:  Int J Environ Res Public Health       Date:  2022-09-06       Impact factor: 4.614

3.  Effects and mechanisms of action of sildenafil citrate in human chorionic arteries.

Authors:  Chrisen H Maharaj; Daniel O'Toole; Tadhg Lynch; John Carney; James Jarman; Brendan D Higgins; John J Morrison; John G Laffey
Journal:  Reprod Biol Endocrinol       Date:  2009-04-23       Impact factor: 5.211

Review 4.  Cyclic AMP signalling pathways in the regulation of uterine relaxation.

Authors:  Wei Yuan; Andrés López Bernal
Journal:  BMC Pregnancy Childbirth       Date:  2007-06-01       Impact factor: 3.007

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.